2 hrs ago
Have HIV? Get Hip to Hep C
A discussion about the risk of transmitting or contracting HIV without mentioning Hepatitis C is like talking about Clyde Barrow without Bonnie Parker.
6 hrs ago
Kansas City InfoZine
Sovaldi Approved for Chronic Hepatitis C
Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection.
12 hrs ago
EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus
The European Association for the Study of the Liver today publishes their revised Clinical Practice Guidelines on the management of hepatitis C virus infection .
Sun Dec 08, 2013
Diabetes identified as risk factor for liver cancer across ethnic groups
Diabetes was associated with an increased risk for developing a type of liver cancer called hepatocellular carcinoma, and this association was highest for Latinos, followed by Hawaiians, African-Americans, and Japanese-Americans, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in ... (more)
The Newark Star-Ledger
Proton therapy center in Franklin is gaining traction in cancer treatment
Liz D'Amato has a story that is all too common. In November of last year, the mother of three from Dayton received a phone call that confirmed a diagnosis thousands of women receive each year: cancer.
Fri Dec 06, 2013
FDA OKs Major New Hepatitis C Drug, Sovaldi
The U.S. Food and Drug Administration has approved Gilead Sciences' hotly anticipated Sovaldi , a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C virus , including those coinfected with HIV and those who have liver cancer and are awaiting a transplant.
Hampton Roads Daily Press
'Breakthrough' hepatitis C treatment was tested by Bon Secours liver specialist
In clinical trials, the polymerase inhibitor, the first used in hepatitis C treatment, has shown a more than 90 percent success rate in curing the deadly virus that causes liver failure and cancer of the liver .
3-year-old Huntley girl battles rare liver cancer
HUNTLEY – Lauren Felde didn't know what to think earlier this fall when she could feel a lump near the stomach of her three-year-old daughter Payton.
FDA approves faster, easier treatment for hepatitis C
Sovaldi, a new medication for hepatitis C that can be paired with other drugs to make treatment of the liver-damaging disease faster, easier and more effective, got approval from the Food and Drug Administration Friday.
WPTV Local News
Possible new treatment for hepatitis C
One of the main treatment options is an injectable drug called interferon. But its side effects are so severe only half of patients can tolerate it.
Thu Dec 05, 2013
Grieving Family Turns to Crowdfunding
She had been for several years in fact. On November 22nd, she went into the hospital for a procedure to remove more cancer from her liver.
Victorville Daily Press
New hope for hepatitis C Hesperia man cured by new medication
"The trainer sent me to the doctor to make sure I wasn't going to croak," Storch said.
National Public Radio
FDA Expected To Approve New, Gentler Cure For Hepatitis C
The Food and Drug Administration is expected any day now to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer.
National Public Radio
FDA Set To Approve Hepatitis Drug
The Food and Drug Administration is expected soon to approve the first in a new class of drugs that can cure the leading cause of liver failure and liver cancer.
Wed Dec 04, 2013
9-year-old cancer survivor gives Christmas to other patients
The 9-year-old was a patient at Primary Children's Hospital last November, when he was diagnosed with his second bout of cancer - acute myeloid leukemia, caused by the chemotherapy he received for stage 4 liver cancer he had as a toddler.
BioAlliance Pharma: Approval to start ReLive (Livatag ) Phase III...
BioAlliance Pharma: Approval to start ReLive Phase III Clinical Trial in Primary Liver Cancer in the U.S. and Germany BioAlliance Pharma SA , an innovative Company dedicated to the development of orphan oncology and to supportive care products, announces that it has received authorization to start its Phase III ReLive clinical trial in primary ... (more)
Tue Dec 03, 2013
Liver stiffness can be used for risk stratification in chronic liver diseases
Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases, reports the most recent issue of Clinical Gastroenterology & Hepatology.
Prayers Requested: ThreePuttinDude
"In late September/early October, he was diagnosed with metastatic liver cancer.
Mon Dec 02, 2013
Genomic Testing for HCV
Hepatitis C is finally gaining significant public awareness, thanks to the CDC and other organizations.
Sun Dec 01, 2013
Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.
Hepatocellular carcinoma is a severe complication of advanced liver disease with a worldwide incidence of more than 600,000 patients per year.